Skip to main content
Vigonvita Life Sciences Co., Ltd. logo

Vigonvita Life Sciences Co., Ltd. — Investor Relations & Filings

Ticker · 2630 ISIN · CNE1000076N3 HKEX Manufacturing
Open in API
Filings indexed 43 across all filing types
Latest filing 2026-05-07 Regulatory Filings
Country HK Hong Kong
Listing HKEX 2630

About Vigonvita Life Sciences Co., Ltd.

http://www.vigonvita.cn

Vigonvita Life Sciences Co., Ltd. is a biopharmaceutical company focused on the discovery, development, and commercialization of innovative small-molecule drugs. The company operates an integrated R&D platform targeting high-need therapeutic areas, specifically neurological and neuropsychiatric disorders, reproductive health, and viral infections. Its comprehensive pipeline includes the oral nucleoside antiviral candidate MINDVY® (VV116), which has been clinically studied for COVID-19 and RSV, and ONVITA® (TPN171). Vigonvita emphasizes high-quality development, evidenced by its participation in significant national programs, including the National Key R&D Program and the Major New Drug Innovation Technology Major Project, often involving international clinical research collaborations.

Recent filings

Filing Released Lang Actions
Monthly Return of Equity Issuer on Movements in Securities for the Month Ended 30 April 2026
Regulatory Filings
2026-05-07 English
(1) PROPOSED ABOLITION OF THE SUPERVISORY COMMITTEE AND AMENDMENTS TO THE ARTICLES OF ASSOCIATION AND ITS APPENDICES; (2) ELECTION OF THE NEW SESSION OF THE BOARD; AND (3) POSTPONEMENT OF THE ANNUAL G
Regulatory Filings
2026-04-30 English
2025 ANNUAL REPORT
Regulatory Filings
2026-04-30 English
Articles of Association
Governance Information Classification · 90% confidence The document is titled “Articles of Association” and comprises the company’s constitutional governance charter, detailing share capital, shareholder meetings, board composition, management structure, audit provisions, and amendment procedures. It is a governance rulebook rather than an earnings announcement, proxy statement, or annual/quarterly financial report. This aligns precisely with the Governance Information category (Code: CGR).
2026-04-23 English
POLL RESULTS OF THE EXTRAORDINARY GENERAL MEETING HELD ON APRIL 23, 2026
Declaration of Voting Results & Voting Rights Announcements Classification · 93% confidence The document is an announcement of the poll results of an Extraordinary General Meeting (EGM), detailing vote counts, percentages, and resolutions passed. It fits the category of official voting results announcements. Therefore, it should be classified under Declaration of Voting Results & Voting Rights Announcements (DVA).
2026-04-23 English
PROXY FORM FOR THE EXTRAORDINARY GENERAL MEETING TO BE HELD ON THURSDAY, APRIL 23, 2026
Proxy Solicitation & Information Statement Classification · 99% confidence The document is a proxy form for an Extraordinary General Meeting, providing shareholders with voting instructions and appointment of proxies. This falls under materials sent to shareholders to request votes, matching the definition of Proxy Solicitation & Information Statement (PSI).
2026-04-08 English

Browse filings by year

2 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.